Page last updated: 2024-08-24

topotecan and Uterine Neoplasms

topotecan has been researched along with Uterine Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Einstein, MH; Goldberg, GL; Gupta, D; Huang, GS; Kim, M; Kuo, DY; Owers, RL; Shahabi, S	1
DeBernardo, RL; Eaton, SM; Frasure, HE; Fusco, NL; Heugel, AM; Smith, DA; von Gruenigen, VE; Waggoner, SE	1
Beck, WT; Ee, PL; He, X; Ross, DD	1
Blessing, JA; Lee, YC; Miller, DS; Munkarah, A; Schilder, J	1
Blessing, JA; Kilgore, LC; Mannel, R; Miller, DS; Van Le, L	1

Trials

4 trial(s) available for topotecan and Uterine Neoplasms

Article	Year
A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers. Gynecologic oncology, 2009, Volume: 113, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Ovarian Neoplasms; Survival Analysis; Taxoids; Topotecan; Uterine Neoplasms	2009
Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study. Anti-cancer drugs, 2012, Volume: 23, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anemia; Cohort Studies; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Topoisomerase I Inhibitors; Topotecan; Uterine Neoplasms	2012
Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecologic oncology, 2005, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinosarcoma; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Topotecan; Uterine Neoplasms	2005
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Cohort Studies; Disease Progression; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Leiomyosarcoma; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Remission Induction; Thrombocytopenia; Topotecan; Uterine Neoplasms	2000

Other Studies

1 other study(ies) available for topotecan and Uterine Neoplasms

Article	Year
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference. Molecular cancer therapeutics, 2004, Volume: 3, Issue:12 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cells; Choriocarcinoma; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estradiol; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mitoxantrone; Neoplasm Proteins; Pregnancy; RNA Interference; RNA, Messenger; Topotecan; Tumor Cells, Cultured; Uterine Neoplasms	2004

Article

Year

Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.

Molecular cancer therapeutics, 2004, Volume: 3, Issue:12

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cells; Choriocarcinoma; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estradiol; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mitoxantrone; Neoplasm Proteins; Pregnancy; RNA Interference; RNA, Messenger; Topotecan; Tumor Cells, Cultured; Uterine Neoplasms

2004